Nathalie Boeglin
Nathalie Boeglin is Executive Director of Regulatory Science at Orchard Therapeutics.
JournalHM10: Strengthening Europe’s clinical trials competitiveness
This is a report of the HM10 session that took place at this year’s Symposium.
JournalHM5/MD1/IVD1: Programme COMBINE – Accelerating clinical trials and medical innovation in the EU
This is a report of the HM5/MD1/IVD1 session that took place at this year’s Symposium.